Antler Bio, a British AgriTech company, develops gene expression technology to assist dairy farmers in increasing milk yield and improving herd health. The company announced a $3.9 million investment round, bringing its total capital raised to $7.8 million including grants.
The round was led by The First Thirty Ventures, a venture capital firm focused on early-stage agricultural technologies. Participating investors included Endgame Capital and regenerative agriculture angel syndicate Generation-RE.
